Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

NCT02328963 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Transplantation Infection
Cytomegalovirus Infection

Interventions

DRUG: Everolimus
DRUG: mycophenolic acid

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]